The findings strengthen the mechanistic link between chronic IL-1 signaling and lung tumorigenesis, as suggested by delayed progression of diverse molecular subtypes of lung cancer subsequent to reduction in tumor-promoting inflammation [51,52]. The gene discussed is IL1B; the disease is lung carcinoma.